vacv strain
Recently Published Documents


TOTAL DOCUMENTS

12
(FIVE YEARS 0)

H-INDEX

10
(FIVE YEARS 0)

2020 ◽  
Author(s):  
Jonas D. Albarnaz ◽  
Hongwei Ren ◽  
Alice A. Torres ◽  
Evgeniya V. Shmeleva ◽  
Carlos A. Melo ◽  
...  

ABSTRACTThe evolutionary arms race between hosts and their viruses drove the evolution of complex immune systems in mammals and sophisticated immune evasion mechanisms by viruses. Mammalian antiviral defences require sensing of virus infection and stimulation of the expression of interferons and cytokines via the activation of NF-κB and other immune signalling pathways. Viruses antagonise these host antiviral defences by interfering with immune sensing and signal transduction and blocking the actions of interferons and cytokines. Here we show that a viral protein mimics the transcription activation domain of p65, the transcriptionally active subunit of NF-κB. The C terminus of vaccinia virus (VACV) protein F14 (residues 51-73) activates transcription when fused to a DNA-binding domain-containing protein and associates with NF-κB co-activator CBP, disrupting its interaction with p65. Consequently, F14 diminishes CBP-mediated acetylation of p65 and the downstream recruitment of RNA polymerase II processivity factor BRD4 to the promoter of NF-κB-responsive gene CXCL10, thereby inhibiting the expression and secretion of CXCL10 upon stimulation with TNF-α. A VACV strain engineered to lack F14 caused reduced lesions in an intradermal model of infection, showing that F14 contributes to virulence. Our results uncover a mechanism by which viruses disarm the antiviral defences through molecular mimicry of a conserved protein of the host’s immune system.



2014 ◽  
Vol 95 (12) ◽  
pp. 2757-2768 ◽  
Author(s):  
David L. Veyer ◽  
Carlos Maluquer de Motes ◽  
Rebecca P. Sumner ◽  
Louisa Ludwig ◽  
Benjamin F. Johnson ◽  
...  

Vaccinia virus (VACV) is a large dsDNA virus encoding ~200 proteins, several of which inhibit apoptosis. Here, a comparative study of anti-apoptotic proteins N1, F1, B13 and Golgi anti-apoptotic protein (GAAP) in isolation and during viral infection is presented. VACVs strains engineered to lack each gene separately still blocked apoptosis to some degree because of functional redundancy provided by the other anti-apoptotic proteins. To overcome this redundancy, we inserted each gene separately into a VACV strain (vv811) that lacked all these anti-apoptotic proteins and that induced apoptosis efficiently during infection. Each protein was also expressed in cells using lentivirus vectors. In isolation, each VACV protein showed anti-apoptotic activity in response to specific stimuli, as measured by immunoblotting for cleaved poly(ADP ribose) polymerase-1 and caspase-3 activation. Of the proteins tested, B13 was the most potent inhibitor, blocking both intrinsic and extrinsic stimuli, whilst the activity of the other proteins was largely restricted to inhibition of intrinsic stimuli. In addition, B13 and F1 were effective blockers of apoptosis induced by vv811 infection. Finally, whilst differences in induction of apoptosis were barely detectable during infection with VACV strain Western Reserve compared with derivative viruses lacking individual anti-apoptotic genes, several of these proteins reduced activation of caspase-3 during infection by vv811 strains expressing these proteins. These results illustrated that vv811 was a useful tool to determine the role of VACV proteins during infection and that whilst all of these proteins have some anti-apoptotic activity, B13 was the most potent.



2014 ◽  
Vol 89 (1) ◽  
pp. 776-783 ◽  
Author(s):  
Min Fang ◽  
Sanda Remakus ◽  
Felicia Roscoe ◽  
Xueying Ma ◽  
Luis J. Sigal

ABSTRACTIt has been shown in various infection models that CD4+T cell help (TH) is necessary for the conditioning, maintenance, and/or recall responses of memory CD8+T cells (CD8M). Yet, in the case of vaccinia virus (VACV), which constitutes the vaccine used to eradicate smallpox and is a candidate vector for other infectious diseases, the issue is controversial because different groups have shown either THdependence or independence of CD8Mconditioning, maintenance, and/or recall response. In agreement with some of these groups, we show that THplays a role in, but is not essential for, the maintenance, proliferation, and effector differentiation of polyclonal memory CD8+T cells after infection with wild-type VACV strain Western Reserve. More important, we show that unhelped and helped anti-VACV memory CD8+T cells are similarly efficient at protecting susceptible mice from lethal mousepox, the mouse equivalent of human smallpox. Thus, THis not essential for the conditioning and maintenance of memory CD8+T cells capable of mounting a recall response strong enough to protect from a lethal natural pathogen. Our results may partly explain why the VACV vaccine is so effective.IMPORTANCEWe used vaccinia virus (VACV)—a gold standard vaccine—as the immunogen and ectromelia virus (ECTV) as the pathogen to demonstrate that the conditioning and maintenance of anti-VACV memory CD8+T cells and their ability to protect against an orthopoxvirus (OPV) infection in its natural host can develop in the absence of CD4+T cell help. Our results provide important insight to our basic knowledge of the immune system. Further, because VACV is used as a vaccine in humans, our results may help us understand how this vaccine induces protective immunity in this species. In addition, this work may partly explain why VACV is so effective as a vaccine.



2014 ◽  
Vol 95 (2) ◽  
pp. 466-471 ◽  
Author(s):  
Bianca M. Dobson ◽  
David C. Tscharke

Modified vaccinia virus Ankara (MVA) is a candidate vaccine vector that is severely attenuated due to mutations acquired during several hundred rounds of serial passage in vitro. A previous study used marker rescue to produce a set of MVA recombinants with improved replication on mammalian cells. Here, we extended the characterization of these rescued MVA strains and identified vaccinia virus (VACV) gene F5L as a determinant of plaque morphology but not replication in vitro. F5 joins a growing group of VACV proteins that influence plaque formation more strongly than virus replication and which are disrupted in MVA. These defective genes in MVA confound the interpretation of marker rescue experiments designed to map mutations responsible for the attenuation of this important VACV strain.



2013 ◽  
Vol 94 (9) ◽  
pp. 2070-2081 ◽  
Author(s):  
Brian J. Ferguson ◽  
Camilla T. O. Benfield ◽  
Hongwei Ren ◽  
Vivian H. Lee ◽  
Gordon L. Frazer ◽  
...  

Vaccinia virus (VACV) expresses many proteins that are non-essential for virus replication but promote virulence by inhibiting components of the host immune response to infection. These immunomodulators include a family of proteins that have, or are predicted to have, a structure related to the B-cell lymphoma (Bcl)-2 protein. Five members of the VACV Bcl-2 family (N1, B14, A52, F1 and K7) have had their crystal structure solved, others have been characterized and a function assigned (C6, A46), and others are predicted to be Bcl-2 proteins but are uncharacterized hitherto (N2, B22, C1). Data presented here show that N2 is a nuclear protein that is expressed early during infection and inhibits the activation of interferon regulatory factor (IRF)3. Consistent with its nuclear localization, N2 inhibits IRF3 downstream of the TANK-binding kinase (TBK)-1 and after IRF3 translocation into the nucleus. A mutant VACV strain Western Reserve lacking the N2L gene (vΔN2) showed normal replication and spread in cultured cells compared to wild-type parental (vN2) and revertant (vN2-rev) viruses, but was attenuated in two murine models of infection. After intranasal infection, the vΔN2 mutant induced lower weight loss and signs of illness, and virus was cleared more rapidly from the infected tissue. In the intradermal model of infection, vΔN2 induced smaller lesions that were resolved more rapidly. In summary, the N2 protein is an intracellular virulence factor that inhibits IRF3 activity in the nucleus.



2011 ◽  
Vol 92 (10) ◽  
pp. 2405-2410 ◽  
Author(s):  
Benjamin F. Johnson ◽  
Yasuhiro Kanatani ◽  
Tatsuya Fujii ◽  
Tomoya Saito ◽  
Hiroyuki Yokote ◽  
...  

In response to potential bioterrorism with smallpox, members of the Japanese Self-Defense Forces were vaccinated with vaccinia virus (VACV) strain LC16m8, an attenuated smallpox vaccine derived from VACV strain Lister. The serological response induced by LC16m8 to four virion-surface proteins and the intracellular mature virus (IMV) and extracellular enveloped virus (EEV) was investigated. LC16m8 induced antibody response against the IMV protein A27 and the EEV protein A56. LC16m8 also induced IMV-neutralizing antibodies, but unlike the VACV strain Lister, did not induce either EEV-neutralizing antibody or antibody to EEV protein B5, except after revaccination. Given that B5 is the only target for EEV-neutralizing antibody and that neutralization of both IMV and EEV give optimal protection against orthopoxvirus challenge, these data suggest that immunity induced by LC16m8 might be less potent than that deriving from strain Lister. This potential disadvantage should be balanced against the advantage of the greater safety of LC16m8.



2008 ◽  
Vol 89 (12) ◽  
pp. 2992-2997 ◽  
Author(s):  
Claire M. Midgley ◽  
Mike M. Putz ◽  
Jonathan N. Weber ◽  
Geoffrey L. Smith

The antibody responses elicited by immunization of humans with vaccinia virus (VACV) strains Lister, Dryvax and NYVAC have been determined and compared. Neutralizing antibodies against intracellular mature virus (IMV) and extracellular enveloped virus (EEV), and binding antibody titres (ELISA) against the EEV protein B5, the IMV proteins A27 and H3, and VACV-infected cell lysate were measured. Lister and Dryvax induced broadly similar antibody titres, consistent with the fact that these vaccines each protected against smallpox. In contrast, antibody titres induced by NYVAC were significantly lower than those induced by both Lister and Dryvax. Moreover, there were qualitative differences with NYVAC-immunized subjects failing to induce A27-specific antibodies. These observations suggest that although NYVAC is a safer VACV strain, it does not induce an optimal VACV-specific antibody response. However, NYVAC strains engineered to express antigens from other pathogens remain promising candidate vaccines for immunization against other diseases.



2008 ◽  
Vol 89 (10) ◽  
pp. 2377-2387 ◽  
Author(s):  
Aodhnait S. Fahy ◽  
Richard H. Clark ◽  
Emily F. Glyde ◽  
Geoffrey L. Smith

The vaccinia virus (VACV) strain Western Reserve C16 protein has been characterized and its effects on virus replication and virulence have been determined. The C16L gene is present in the inverted terminal repeat and so is one of the few VACV genes that are diploid. The C16 protein is highly conserved between different VACV strains, and also in the orthopoxviruses variola virus, ectromelia virus, horsepox virus and cowpox virus. C16 is a 37.5 kDa protein, which is expressed early during infection and localizes to the cell nucleus and cytoplasm of infected and transfected cells. The loss of the C16L gene had no effect on virus growth kinetics but did reduce plaque size slightly. Furthermore, the virulence of a virus lacking C16L (vΔC16) was reduced in a murine intranasal model compared with control viruses and there were reduced virus titres from 4 days post-infection. In the absence of C16, the recruitment of inflammatory cells in the lung and bronchoalveolar lavage was increased early after infection (day 3) and more CD4+ and CD8+ T cells expressed the CD69 activation marker. Conversely, late after infection with vΔC16 (day 10) there were fewer T cells remaining, indicating more rapid clearance of infection. Collectively, these data indicate that C16 diminishes the immune response and is an intracellular immunomodulator.



2007 ◽  
Vol 88 (12) ◽  
pp. 3249-3259 ◽  
Author(s):  
Christine Meisinger-Henschel ◽  
Michaela Schmidt ◽  
Susanne Lukassen ◽  
Burkhard Linke ◽  
Lutz Krause ◽  
...  

Chorioallantois vaccinia virus Ankara (CVA) is the parental virus of modified vaccinia virus Ankara (MVA), which was derived from CVA by more than 570 passages in chicken embryo fibroblasts (CEF). MVA became severely host-cell-restricted to avian cells and has strongly diminished virulence in mammalian hosts, while maintaining good immunogenicity. We determined the complete coding sequence of the parental CVA and mapped the exact positions of the six major deletions that emerged in the MVA genome. All six major deletions occurred in regions of the CVA genome where one or more truncated or fragmented open reading frames (ORFs) pre-existed. The CVA genome contains 229 ORFs of which 51 are fragments of full-length orthopoxvirus (OPV) genes, including fragmented orthologues of C9L and M1L (encoding two well-conserved ankyrin-like proteins), A39R (encoding a semaphorin-like protein) and A55R (encoding a kelch-like protein). Phylogenetic analysis demonstrated that MVA was most closely related to CVA, followed by the vaccinia virus (VACV) strain DUKE, a patient-derived isolate of the Dryvax vaccine virus. Loss or mutation of genes outside the six major deletions are assumed to contribute to the restricted host range phenotype of MVA. In support of this notion, deletions, insertions and non-synonymous mutations were found in 122 of the 195 ORFs remaining in MVA when compared with their CVA counterparts. Thus, detailed knowledge of the CVA genomic sequence is a prerequisite to further dissect the genetic basis of the MVA host range phenotype as well as the particular immunological properties of MVA.



2006 ◽  
Vol 87 (6) ◽  
pp. 1521-1529 ◽  
Author(s):  
Philippa M. Beard ◽  
Graham C. Froggatt ◽  
Geoffrey L. Smith

The vaccinia virus (VACV) protein A55 is a BTB/kelch protein with a broad-complex, tramtrack and bric-a-brac (BTB) domain in the N-terminal region and five kelch repeats in the C-terminal half. The BTB/kelch subgroup of the kelch superfamily of proteins has been associated with a wide variety of functions including regulation of the cytoskeleton. VACV contains three genes predicted to encode BTB/kelch proteins: A55R, F3L and C2L. The A55R gene product has been identified as an intracellular protein of 64 kDa that is expressed late in infection. A VACV strain lacking 93.6 % of the A55R open reading frame (vΔA55) was constructed and found to have an unaltered growth rate in vivo but a different plaque morphology and cytopathic effect, as well as reduced development of VACV-induced Ca2+-independent cell/extracellular matrix adhesion. In a murine intradermal model of VACV infection, a virus lacking the A55R gene induced larger lesions than wild-type and revertant control viruses.



Sign in / Sign up

Export Citation Format

Share Document